Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Cohort Study and Mechanistic Research on Individualized Comprehensive Treatment After Standard Treatment for Advanced Hepatocellular Carcinoma

NCT06893887 is registered in ClinicalTrials.gov with Nanjing Tianyinshan Hospital as lead sponsor.

NCT NCT06893887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06893887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Cohort Study and Mechanistic Research on Individualized Comprehensive Treatment After Standard Treatment for Advanced Hepatocellular Carcinoma
Lead sponsor
Nanjing Tianyinshan Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 22, 2025
Completion date
December 15, 2028
Enrollment
270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma(hcc)